article thumbnail

Researcher finds increased risk of cardiovascular disease in people with hereditary lipid disorders

Medical Xpress - Cardiology

Tigist Wodaje from the Endocrinology Unit at the Department of Medicine, Huddinge (MedH), is defending her thesis, "Hereditary hypercholesterolemia and cardiovascular disease: functional and epidemiological aspects," on 14 December, 2023. The main supervisor is Jonas Brink (MedH).

article thumbnail

Controlling lipid levels with fewer side effects possible with new drug

Science Daily - Heart Disease

Mice administered the drug showed decreased lipid levels in the liver and blood, with fewer side effects in the liver, heart, and bones compared to existing compounds. The findings suggest an effective treatment for lipid disorders such as dyslipidemia.

article thumbnail

Cholesterol’s Star Role in Dementia Prevention: New Insights from the 2024 Lancet Dementia Report 

Cardiometabolic Health Congress

Subscribe below and stay informed in this critical field, and you’ll be equipped to deliver top-tier care in managing lipid disorders and cognitive health for improved patient outcomes.

article thumbnail

Creative Alliances in Cardiorenal Metabolic Management: A Game Changer (Part 1) 

Cardiometabolic Health Congress

Key contributions: Management of complex diabetes cases, including those requiring advanced technologies like continuous glucose monitoring and insulin pumps Evaluation and treatment of secondary causes of hypertension Assessment and management of lipid disorders Diagnosis and treatment of endocrine disorders affecting cardiometabolic health (..)

article thumbnail

FDA Approves Wegovy for Cardiovascular Risk Reduction in Adults with Known Heart Disease and Overweight or Obesity

DAIC

director of the Division of Diabetes, Lipid Disorders, and Obesity in the FDA’s Center for Drug Evaluation and Research , in a statement issued by the FDA. This patient population has a higher risk of cardiovascular death, heart attack and stroke.

Obesity 111